返回 Agenda
Session 5 - ASEAN Townhall: Empowering the ASEAN patients – Regulators as a catalyst for change
Session Chair(s)
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore
James Leong, PhD, MPharm
Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
Duke NUS Medical School, Singapore
Panel members to discuss the efficiency, equitable and sustainability of healthcare systems in ASEAN and review progress in country and identify next steps. Where are we now in ASEAN region compared with global best practices for a better-informed patient-centric health system). Do ASEAN patients have the capacity and opportunity to engage in shared decision-making within the clinical setting, the patient’s community, and the wider healthcare system? What is the key lessons learned from the Covid-19 pandemic and the way forward. Hear deliberation about these topics and more from the regulators from the ASEAN countries.
Speaker(s)
Empowering the ASEAN patients - Regulators as a Cataylst for Change
Jesusa Joyce N Cirunay
Food and Drug Administration Philippines, Philippines
Director IV , Center for Drug Regulation and Research (CDRR)
Rajakanth R
Manifeste LLP, Singapore
Principal Consultant
Contributing Panelist
Jesusa Joyce N Cirunay
Food and Drug Administration Philippines, Philippines
Director IV , Center for Drug Regulation and Research (CDRR)
Contributing Panelist
Kum Cheun Wong, PharmD
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
Head Asia Pacific Regulatory & Development Policy
Contributing Panelist
Martin Lim, MBA, MS
ONWARD Health Research, Singapore
Co-Founder and CEO